Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
and ALK7 (> 0
Fatostatin A can prevent increases in body weight
939 (2008)
SU5416 selectively inhibits VEGF-driven mitogenesis in a dose-dependent manner with IC50 of 0
A significant reduction of PCSK9 promoter activity by Anacetrapib (ANA) is detected at 3 µM concentration (−22%
UK-5099 - CAS# 56396-35-1 66052 and ALK7 (> 0UK 5099, CAS No. 56396 35 1, is a specific and potent mitochondrial pyruvate carrier blocker (MCK blocker). The UK5099 treated cells showed significantly higher proportion of side population (SP) fraction and expressed higher levels of stemness markers Oct3 4 and Nanog. Chemosensitivity examinations revealed that the UK5099 treated cells became more resistant to chemotherapy compared to the non treated cells. MPC blocker (UK5099) application may be an